J&J says AI cuts drug lead development time in half
Johnson & Johnson says artificial intelligence is reducing by 50% the time needed to generate early drug development leads, accelerating how quickly promising compounds are identified. According to J&J, AI is helping screen large pools of chemical and biologic candidates faster, improving lead optimization in areas such as cancer and immunology. The company says it […]
